Managing liver failure

Postgraduate Medical Journal

Volumn 78, Issue 925, 2002, Pages 660-667

  Kelly, Deirdre A ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; AMOXICILLIN; CARBAMAZEPINE; CEPHALOSPORIN; CORTICOSTEROID; DEFEROXAMINE; FLUCONAZOLE; HALOTHANE; HEPATITIS B VACCINE; ISONIAZID; LACTULOSE; PARACETAMOL; PENICILLAMINE; PREDNISOLONE; PROSTAGLANDIN E1; PYRIDOXINE; RANITIDINE; SELENIUM; SUCRALFATE; TOCOFERSOLAN; TRIMETHOPRIM; VALPROIC ACID; VITAMIN K GROUP; ZINC;

AUTOIMMUNE HEPATITIS; BILE DUCT ATRESIA; BILIARY TRACT DISEASE; BLOOD CLOTTING DISORDER; BRAIN DISEASE; BRAIN EDEMA; CHILD; CHILD CARE; CLINICAL FEATURE; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; EARLY DIAGNOSIS; ESOPHAGUS VARICES; FLUID BALANCE; GASTROINTESTINAL HEMORRHAGE; GRAFT REJECTION; HEMOCHROMATOSIS; HEPATITIS B; HUMAN; INTENSIVE CARE; INTRAHEPATIC CHOLESTASIS; JAUNDICE; KIDNEY FAILURE; LIVER FAILURE; LIVER TRANSPLANTATION; METABOLIC DISORDER; NUTRITIONAL SUPPORT; PATIENT REFERRAL; QUALITY OF LIFE; REVIEW; SCLEROTHERAPY; SEPSIS; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS HEPATITIS; WILSON DISEASE;

CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; HEMORRHAGE; HUMANS; INFANT; INFANT, NEWBORN; LIVER FAILURE; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; METABOLIC DISEASES; SEPSIS; VARICOSE VEINS;

EID: 0036873139     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.925.660     Document Type: Review

References (36)

1. Alonso EM, Superina RA, Whitington PF. Fulminant hepatitis and acute liver failure. In: Kelly DA, ed. Diseases of the Liver and Biliary System in Children. Oxford: Blackwell Science, 1999:77-96.
2. Beath SV, Boxall EH, Watson RM, et al. Fulminant hepatitis B in infants born to anti-Hbe hepatitis B carrier mothers. BMJ 1992;304:1169-70.
3. Friedt M, Gerner P, Lausch E, et al. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B. Hepatology 1999;29:1252-8.
4. Sigurdsson L, Reyes J, Kocoshis SA, et al. Neonatal hemochromatosis: Outcome of pharmacologic and surgical techniques. J Pediatr Gastroenterol Nutr 1998;26:85-9
5. Lindstetd S, Holme E, Lock EA, et al. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 1992;340:813-7.
6. Mohan N, McKiernan P, Preece MA, et al. Indications and outcome of liver transplantation in tyrosinemia type 1. Eur J Pediatr 1999;158:S49-54.
7. Thomson M, McKiernan P, Buckels J, et al. Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplantation in childhood. J Pediatr Gastroenterol Nutr 1998;26:478-81.
8. Jabado N, de Graeff-Meeder ER, Cavazzana-Calvo M, et al. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood 1997;90:4743-8.
9. Gregorio GV, Portmann B, Karani J, et al. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study. Hepatology 2001;33:544-53.
10. Kelly DA. Liver transplantation: To do or not to do? Pediatric Transplantation 2000;4:170-2.
11. Nazer H, Ede RJ, Mowat AP, et al. Wilson's disease: Clinical presentation and use of prognostic index. Gut 1986;27:1377-81.
12. Ellis AJ, Hughes RD, Wendon JA, et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996;6:1557.
13. Bhaduri BR, Mieli-Vergani G. Fulminant hepatic failure: Pediatric aspects. Semin Liver Dis 1996;16:349-55.
14. European Liver Transplant Registry, 2001 (http://www.eltr.org).
15. McKiernan PJ, Baker AJ, Kelly DA. The frequency and outcome of biliary atresia in the UK and Ireland. Lancet 2000;355:25-9.
16. Primhak RA, Tanner MS. Alpha-1 antitrypsin deficiency. Arch Dis Child 2001;85:2-5.
17. Bull LN, Carlton VE, Stricker NL, et al. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC-1] and Byler syndrome): Evidence for heterogeneity. Hepatology 1997;26:155-64.
18. Thompson R, Strautnieks S. Inherited disorders of transport in the liver. Curr Opin Genet Dev 2000;10:310-3.
19. Carleton VC, Knisely AS, Freimer NB. Mapping of a locus for progressive familial intrahepatic cholestasis (Byler disease) to 18q21-q22, the benign recurrent intrahepatic cholestasis region. Hum Mol Genet 1995;4:1049-53.
20. Lindblad A, Glaumann H, Srandvik B. A 2 year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis associated liver disease. Hepatology 1998;27:166-74.
21. Couetil JP, Soubrane O, Houssain DP, et al. Combined heart-lung-liver, and isolated liver transplantation for cystic fibrosis in children. Transpl Int 1997;10:33-9.
22. Rashid M, Roberts E. Non-alcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000;30:48-53.
23. Shepherd R. Complications and management of chronic liver disease. In: Kelly DA, ed. Diseases of the Liver and Biliary System in Children. Oxford: Blackwell Science, 1999: 189-210.
24. Maksoud JG, Goncalves ME, Porta G, et al. The endoscopic and surgical management of portal hypertension in children: Analysis of 124 cases. J Pediatr Surg 1991;26:178-81.
25. Paquet KJ, Lazar A. Current therapeutic strategy in bleeding oesophageal varices in babies and children and long term results of endoscopic paravariceal sclerotherapy over twenty years. Eur J Pediatr Surg 1994;4:165-72.
26. Lee WS, John P, McKiernan P, et al. Inferior vena cava occlusion and protein-losing enteropathy after liver transplantation in children. J Pediatr Gastroenterol Nutr 2002;34:413.
27. Heyman MB, LaBerge JM. Role of transjugular portosystemic shunt in the treatment of portal hypertension in pediatric patients. J Pediatr Gastroenterol Nutr 1999;29:240-9.
28. Shashidhar H, Langhans N, Grand RJ. Propranolol n prevension of portal hypertensive haemorrhage in children: A pilot study. J Pediatr Gastroenterol Nutr 1999;29:12-17.
29. Mitzner SR, Strange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective randomized, controlled clinical trial. Liver Transplantation 2000;6:277-86.
30. Kelly DA, Mayer AD. Liver transplantation. In: Kelly DA, ed. Diseases of the Liver and Biliary System in Children. Oxford: Blackwell Science, 1999:293-312.
31. Van Mourik I, Melendez H, Thomson M, et al. Efficacy of neoral in the immediate post operative period in children post liver transplantation. Liver Transplant Surgery 1998;6:491-8.
32. Talbot D, Achilleos OA, Gunson BK, et al. Progress in paediatric liver transplantation: The Birmingham experience. J Pediatr Surg 1997;32:710-13.
33. Van Mourik IDM. Long term nutrition and neurodevelopmental outcome of liver transplantation in infants aged less than 12 months. J Pediatr Gastroenterol Nutr 2000;30:269-76.
34. Kelly D, Jara P, Rodeck B. Tacrolimus dual therapy versus cyclosporin-microemulsion triple therapy in paediatric liver transplantation: Results from a multi-centre randomised trial. American Journal of Transplantation 2002:2:351.
35. Holt RI, Broide E, Buchanan CR, et al. Orthotopic liver transplantation reverses the adverse nutritional changes of end stage liver disease in children. Am J Clin Nutr 1997;65:534-42.
36. Carr DB, Larson AM, Schmucker BC, et al. Maternal haemodynamics and pregnancy outcome in women with prior orthotopic liver transplantation. Liver Transplantation 2000;6:213-21.